HIV Waiting Room: Well-informed, HIV treatment-experienced patient looking for ways to simplify his regimen
Infectious DiseasesHIV Waiting Room: Well-informed, HIV treatment-experienced patient looking for ways to simplify his regimen
1.0 AMA PRA Category 1 Credit(s) ™
December 18, 2019
The accreditation for this activity has expired.
Primary Audience:
Infectious Disease and HIV-specialist Physicians
Relevant Terms:
HIV, Sexual health, MSM, HIV and aging, Single tablet, Switching strategies
Carlos Del Rio, MD
Professor
Emory Vaccine Center
Professor and Chair
Hubert Department of Global Health, Rollins School of Public Health
Professor
Department of Medicine, Division of Infectious Diseases
Emory University School of Medicine
Investigator
Emory Center for AIDS Research
Atlanta, Georgia
Bio
Emory Vaccine Center
Carlos Del Rio, MD is Hubert Professor and Chair of the Hubert Department of Global Health at the Rollins School of Public Health of Emory University and Professor of Medicine at Emory University School of Medicine. He is Director for Clinical Sciences and International Research of the Emory CFAR and Director of the Emory AIDS International Training and Research Program.
Dr. Del Rio is a native of Mexico where he was Executive Director of the National AIDS Council of Mexico (CONASIDA, the Federal agency of the Mexican Government responsible for AIDS Policy throughout Mexico), from 1992 through 1996. He was also a member of the Program Coordinating Board of UNAIDS (1995 -97).
Since joining the faculty at Emory in 1996 he has served in many leadership roles including Chief of the Emory Medical Service at Grady Memorial Hospital (2001 – 2009) and Executive Director of the Hope Clinic of the Emory Vaccine Center (2004 – 2006).
Dr. Del Rio is a Member of the Board of Directors of the International AIDS Society-USA, the HIVMA of the Infectious Diseases Society of America (IDSA) and the IDSA. He is a member of the DHHS Panel for Antiretroviral Guidelines for Adults and Adolescents and member of the Advisory Committee on HIV and STD Prevention and Treatment of the Centers for Disease Control and Prevention and Health Resources and Services Administration. He is Senior Clinical Editor for AIDS Research and Human Retroviruses and Associate Editor of AIDS Clinical Care and member of the editorial board of Journal of AIDS, Women, Children and HIV, and Global Public Health. Dr. Del Rio has been a member of four Institute of Medicine Committees on HIV/AIDS issues (The Ryan White Care Act: Data for Resource Allocation, Planning and Evaluation; Methodological Issus on HIV Prevention Trials; HIV Social Security Disability Criteria, and Data Systems for Monitoring HIV Care). Dr. Del Rio has co-authored 5 books, 30 book chapters and over 200 scientific papers.
Richard A. Elion, MD, MA
Clinical Professor of Medicine
George Washington University, School of Medicine
Senior Policy Advisor, Trio Health
Director, HIV/HCV Clinical and Research Program
Washington Health Institute
Washington, District of Columbia
Bio
Dr. Richard Elion is a board certified family medicine physician who graduated from Temple University and completed his residency at Duke Medical Center. In addition to his medical degree, he has a Masters Degree in Counseling & Spiritual Psychology from the University of Santa Monica.| 1. | Utilize HIV-switching strategies that offer simplified dosing and/or improved tolerability for long-term outcomes in patients stable on their current regimens |
| 1. | Utilize HIV-switching strategies that offer simplified dosing and/or improved tolerability for long-term outcomes in patients stable on their current regimens |
HIV Waiting Room: Test Your Skills in Managing These Patients – Well-informed, HIV treatment-experienced patient looking for updates on switching regimens and emerging approaches to treatment
Expiration Date: December 18, 2020
This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by an educational grant from Gilead Sciences, Inc.
Target Audience
This activity is intended for infectious disease and HIV specialist physicians and other clinicians involved in the care of patients with HIV infection
Statement of Need/Program Overview
Patients with HIV will frequently switch regimens due to virologic failure, comorbidities, or desire for simplification. A treatment-experienced patient has different needs than a patient initiating treatment, including antiretroviral (ART) history and existing comorbidities that may be exacerbated by their current ART. Currently, there are many options for switching ART regimens, both within and between classes. This case-based interactive activity focuses on a treatment-experienced, knowledgeable patient who has developed comorbidities due to his current ART regimen, creating a clinical scenario addressing reasons for switching treatment, within- and between-class options, 2-drug regimens, and factors to consider when selecting a new ART regimen.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 80% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 80%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Carlos Del Rio, MD
Consultant/Independent Contractor: Merck & Co., Inc. (Consultant/Scientific input); Grant/Research Support: National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAIDS) – Grant to my institution (Emory Center for AIDS Research), National Institutes of Health (NIH)/BNIAID – Grant to my institution (Emory HIV Clinical Trials Unit)
Richard A. Elion, MD, MA
The following planners and managers reported neither they nor their spouses/life partners have financial relationships or relationships to products or devices they with commercial interests related to the content of this CME activity:
Lindsay Borvansky; Andrea Funk; Liddy Knight; Ashley Cann; Gena Dolson, MS; Stacey JP Ulman, MHS; Jim Kappler, PhD
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Course Viewing Requirements
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
